Cencora filed required disclosures regarding institutional ownership changes with the SEC and received analyst reports from Morgan Stanley.
2 reports, 2 independent
Updated Aug 30
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cencora filed required disclosures regarding institutional ownership changes with the SEC and received analyst reports from Morgan Stanley.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cencora
US drug wholesale company company
-
SEC
Slovak company
-
Morgan Stanley
U.S. investment bank
Related events
- Bristol Myers Squibb filed with the SEC on May 28, 2026, regarding increased institutional ownership and share purchases.
- ICU Medical stock is trading on the electronic exchange, with required ownership disclosures and analyst reports filed with the SEC.
- General Dynamics filed with the SEC on June 6, 2026, regarding required institutional holdings disclosures.
- Morgan Stanley issued research reports and price targets, while institutional investment disclosures were filed with the SEC regarding a new stake purchase in Stanley Black & Decker.
- Clorox filed required institutional holdings reports with the SEC on August 9, 2026.